Pixium Vision Overview

  • Founded
  • 2011
Founded
  • Status
  • Public
  • Employees
  • 26
Employees
  • Stock Symbol
  • ALPIX
Stock Symbol
  • Share Price
  • $1.28
  • (As of Friday Closing)

Pixium Vision General Information

Description

Pixium Vision SA is engaged in the business of developing implantable medical devices to treat blindness resulting from the degeneration of retinal photoreceptor cells.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Stock Exchange
PAR
Primary Office
  • 74 rue du Faubourg Saint-Antoine
  • 75012 Paris
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pixium Vision Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.28 $1.25 $0.59 - $2.90 $73.3M 57.1M 1.02M -$0.31

Pixium Vision Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 46,027 46,027 17,715 31,418
Revenue 1,631 1,631 1,989 1,607
EBITDA (8,799) (8,799) (9,440) (7,329)
Net Income (10,430) (10,430) (11,056) (15,667)
Total Assets 19,841 19,841 15,250 24,504
Total Debt 10,440 10,440 8,515 9,002
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pixium Vision Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pixium Vision‘s full profile, request access.

Request a free trial

Pixium Vision Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Pixium Vision SA is engaged in the business of developing implantable medical devices to treat blindness resulting from
Surgical Devices
Paris, France
26 As of 2020
000.00
000000000 000.00

000000 0

tation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehender
00000000000 0000000
Sylmar, CA
0 As of 0000
00000
000000&0

000000 0

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nu
00000000000 0000000
Melbourne, Australia
0 As of 0000
0000
00000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pixium Vision Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Second Sight Medical Products Formerly VC-backed Sylmar, CA 0 00000 000000&0
000000 000000 0000 Venture Capital-Backed Melbourne, Australia 0 0000 00000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Pixium Vision Executive Team (12)

Name Title Board Seat Contact Info
Llyod Diamond Chief Executive Officer
Offer Nonhoff Chief Financial Officer
Guillaume Buc Chief Technology Officer
José-Alain Sahel Ph.D Co-Founder
Lionel Rousseau Ph.D Co-Founder
You’re viewing 5 of 12 executive team members. Get the full list »

Pixium Vision Board Members (7)

Name Representing Role Since
Bernard Gilly Ph.D iBionext Chairman & Co-Founder 000 0000
You’re viewing 1 of 7 board members. Get the full list »

Pixium Vision Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pixium Vision Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pixium Vision‘s full profile, request access.

Request a free trial